IMDX vs MNDY · rev $271.0K vs P/E 32, rev $1.23B
Insight Molecular Diagnostics Inc. (IMDX) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
IMDX currently screens at market cap $0. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the IMDX and MNDY stock pages for the full models.
Not investment advice.